You are using an older browser version. Please use a supported version for the best MSN experience.

Evofem Biosciences CEO on Birth Control Gel Phexxi

Jun.22 -- Saundra Pelletier, chief executive officer of Evofem Biosciences Inc., talks about the Phexxi, a new birth control gel that is the first non-hormonal contraceptive to win FDA approval in decades. The approval last year marked a rare new option in the contraceptive market, which has been dominated by pills for the past 60 years. Pelletier speaks on "Bloomberg: Quicktake the Lead"
image beaconimage beaconimage beacon